One of the big arguments that insurance companies make about IV ketamine and CRPS is that it affects the liver.
Researchers and physicians, including Dr. Pradeep Chopra, Dr. Philip Getson, and Dr. Jay Joshi, analyzed the medical records of 52 patients who received IV ketamine and not one of them had an abnormal live function test.
Read the full study here and below.